19 results on '"Hoefsloot, E.H. (Lies)"'
Search Results
2. The potential diagnostic yield of whole exome sequencing in pregnancies complicated by fetal ultrasound anomalies
- Author
-
Diderich, K.E.M. (Karin), Romijn, K. (Kathleen), Joosten, A-M.S (Marieke), Govaerts, L.C. (Lutgarde), Polak, M.G. (Marike), Brüggenwirth, H.T. (Hennie), Wilke, M. (Martina), Slegtenhorst, M.A. (Marjon) van, Bever, Y. (Yolande) van, Brooks, A.S. (Alice), Mancini, G.M.S. (Grazia), Laar, I.M.B.H. (Ingrid) van de, Kromosoeto, J.N.R. (Joan), Knapen, M.F.C.M. (Maarten), Go, A.T.J.I. (Attie), Van Opstal, A.R.M. (Diane), Hoefsloot, E.H. (Lies), Galjaard, R-J.H. (Robert-Jan), Srebniak, M.I. (Malgorzata), Diderich, K.E.M. (Karin), Romijn, K. (Kathleen), Joosten, A-M.S (Marieke), Govaerts, L.C. (Lutgarde), Polak, M.G. (Marike), Brüggenwirth, H.T. (Hennie), Wilke, M. (Martina), Slegtenhorst, M.A. (Marjon) van, Bever, Y. (Yolande) van, Brooks, A.S. (Alice), Mancini, G.M.S. (Grazia), Laar, I.M.B.H. (Ingrid) van de, Kromosoeto, J.N.R. (Joan), Knapen, M.F.C.M. (Maarten), Go, A.T.J.I. (Attie), Van Opstal, A.R.M. (Diane), Hoefsloot, E.H. (Lies), Galjaard, R-J.H. (Robert-Jan), and Srebniak, M.I. (Malgorzata)
- Abstract
Introduction: The aim of this retrospective cohort study was to determine the potential diagnostic yield of prenatal whole exome sequencing in fetuses with structural anomalies on expert ultrasound scans and normal chromosomal microarray results. Material and methods: In the period 2013-2016, 391 pregnant women with fetal ultrasound anomalies who received normal chromosomal microarray results, were referred for additional genetic counseling and opted for additional molecular testing pre- and/or postnatally. Most of the couples received only a targeted molecular test and in 159 cases (40.7%) whole exome sequencing (broad gene panels or open exome) was performed. The results of these molecular tests were evaluated retrospectively, regardless of the time of the genetic diagnosis (prenatal or postnatal). Results: In 76 of 391 fetuses (19.4%, 95% CI 15.8%-23.6%) molecular testing provided a genetic diagnosis with identification of (likely) pathogenic variants. In the majority of cases (91.1%, 73/76) the (likely) pathogenic variant would be detected by prenatal whole exome sequencing analysis. Conclusions: Our retrospective cohort study shows that prenatal whole exome sequencing, if offered by a clinical geneticist, in addition to chromosomal microarray, would notably increa
- Published
- 2020
- Full Text
- View/download PDF
3. Is it feasible to select fetuses for prenatal WES based on the prenatal phenotype?
- Author
-
Diderich, K.E.M. (Karin), Joosten, A-M.S (Marieke), Govaerts, L.C. (Lutgarde), Van Opstal, A.R.M. (Diane), Go, A. (Attie), Knapen, M.F.C.M. (Maarten), Galjaard, R-J.H. (Robert-Jan), Hoefsloot, E.H. (Lies), Srebniak, M.I. (Malgorzata), Diderich, K.E.M. (Karin), Joosten, A-M.S (Marieke), Govaerts, L.C. (Lutgarde), Van Opstal, A.R.M. (Diane), Go, A. (Attie), Knapen, M.F.C.M. (Maarten), Galjaard, R-J.H. (Robert-Jan), Hoefsloot, E.H. (Lies), and Srebniak, M.I. (Malgorzata)
- Published
- 2019
- Full Text
- View/download PDF
4. Placental studies elucidate discrepancies between NIPT showing a structural chromosome aberration and a differently abnormal fetal karyotype
- Author
-
Van Opstal, A.R.M. (Diane), van Veen, S. (Stefanie), Joosten, A-M.S (Marieke), Diderich, K.E.M. (Karin), Govaerts, L.C. (Lutgarde), Polak, J. (Joke), van Koetsveld, N. (Nicole), Boter, M. (Marjan), Go, A.T.J.I. (Attie), Papatsonis, D.N.M. (Dimitri), Prinsen, K. (Krista), Hoefsloot, E.H. (Lies), Srebniak, M.I. (Malgorzata), Van Opstal, A.R.M. (Diane), van Veen, S. (Stefanie), Joosten, A-M.S (Marieke), Diderich, K.E.M. (Karin), Govaerts, L.C. (Lutgarde), Polak, J. (Joke), van Koetsveld, N. (Nicole), Boter, M. (Marjan), Go, A.T.J.I. (Attie), Papatsonis, D.N.M. (Dimitri), Prinsen, K. (Krista), Hoefsloot, E.H. (Lies), and Srebniak, M.I. (Malgorzata)
- Abstract
Objective: Placental cytogenetic studies may reveal the origin of discordant noninvasive prenatal testing (NIPT). We performed placental studies to elucidate discordances between NIPT showing a structural chromosome aberration and the fetus having a different chromosome aberration in three cases. Method: Diagnostic testing with genomic SNP microarray was performed in three cases with NIPT showing a duplication on 4q (case 1), a terminal deletion of 13q (case 2), and a terminal deletion of 15q (case 3). Placental studies involved SNP array analysis of cytotrophoblast and mesenchymal core of chorionic villi of four placental quadrants. Clinical follow-up was performed as well. Results: Amniotic fluid revealed a different structural chromosome aberration than predicted by NIPT: a terminal 2q deletion (case 1), a segmental uniparental isodisomy of 13q (case 2), and a terminal duplication of 15q and of 13q (case 3). Placental studies revealed the aberration detected with NIPT in the cytotrophoblast, whereas the fetal karyotype was confirmed in the placental mesenchymal core. Conclusion: Our study shows that targeted cytogenetic investigations for confirmation of NIPT showing a microscopically visible structural chromosome aberration should be avoided, since another aberration, even a submicroscopic one or one involving another chromosome, may be present in the fetus.
- Published
- 2019
- Full Text
- View/download PDF
5. Unexpected finding of uniparental disomy mosaicism in term placentas: Is it a common feature in trisomic placentas?
- Author
-
Van Opstal, A.R.M. (Diane), Diderich, K.E.M. (Karin), Joosten, A-M.S (Marieke), Govaerts, L.C. (Lutgarde), Polak, J. (Joke), Boter, M. (Marjan), Saris, J.J. (Jasper J.), Cheung, W.Y. (Wai Yee), van Veen, S. (Stefanie), van de Helm, R. (Robert), Go, A.T.J.I. (Attie), Knapen, M.F.C.M. (Maarten), Papatsonis, D.N.M. (Dimitri), Dijkman, A., Vries, F.A.T. (Femke) de, Galjaard, R-J.H. (Robert-Jan), Hoefsloot, E.H. (Lies), Srebniak, M.I. (Malgorzata), Van Opstal, A.R.M. (Diane), Diderich, K.E.M. (Karin), Joosten, A-M.S (Marieke), Govaerts, L.C. (Lutgarde), Polak, J. (Joke), Boter, M. (Marjan), Saris, J.J. (Jasper J.), Cheung, W.Y. (Wai Yee), van Veen, S. (Stefanie), van de Helm, R. (Robert), Go, A.T.J.I. (Attie), Knapen, M.F.C.M. (Maarten), Papatsonis, D.N.M. (Dimitri), Dijkman, A., Vries, F.A.T. (Femke) de, Galjaard, R-J.H. (Robert-Jan), Hoefsloot, E.H. (Lies), and Srebniak, M.I. (Malgorzata)
- Abstract
Objective: Non-invasive prenatal testing (NIPT) detects placental chromosome aberrations. When amniocentesis reveals a normal karyotype, confined placental mosaicism (CPM) may be assumed. In order to confirm this, placental cytogenetic studies were performed. Method: NIPT was conducted in the course of the Dutch TRIDENT study. Placentas of 10 cases with NIPT results indicating an autosomal trisomy and showing a normal (N = 9) or low mosaic karyotype (N = 1) in amniotic fluid (AF) were investigated. The cytotrophoblast as well as the mesenchymal core of two to four placental chorionic villi biopsies were studied with single nucleotide polymorphism (SNP) array. Clinical outcome data were collected. Results: In 10/10 cases, CPM was proven. In 3/10 cases trisomy/uniparental disomy (UPD)/biparental disomy (BPD) mosaicism was discovered. In 2/3 cases, all three cell lines were present in the placenta, whereas BPD was found in AF. In 1/3 cases trisomy 22/UPD22 was present in AF while trisomy 22/BPD22 mosaicism was found in the placenta. Five of 10 pregnancies were affected with pre-eclampsia, low birth weight, preterm delivery, and/or congenital malformations. Conclusion: The presence of trisomy/UPD/BPD mosaicism in 3/10 cases that we investigated proves that trisomic zygote rescue may involve multiple rescue events during early embryogenesis. UPD mosaicism, when present in crucial fetal tissues, may explain the abnormal phenotype in undiagnosed cases.
- Published
- 2018
- Full Text
- View/download PDF
6. Heterozygous missense variants of LMX1A lead to nonsyndromic hearing impairment and vestibular dysfunction
- Author
-
Wesdorp, M. (Mieke), de Koning Gans, P.A.M. (P. A M), Schraders, M. (Margit), Oostrik, J. (Jaap), Huynen, M. (Martijn), Venselaar, H. (Hanka), Beynon, A.J. (Andy J.), van Gaalen, J. (Judith), Piai, V. (Vitória), Voermans, N.C. (Nicol), Rossum, M.M. (Michelle) van, Hartel, B.P. (Bas P.), Lelieveld, S.H. (Stefan H.), Wiel, L. (Laurens), Verbist, B. (Berit), Rotteveel, L.J. (Liselotte J.), Dooren, M.F. (Marieke) van, Lichtner, P. (Peter), Kunst, H.P.M. (Henricus P. M.), Feenstra, I. (Ilse), Admiraal, R.J.C. (Ronald J. C.), van Dooren, M.F. (M. F.), de Gier, H.H.W. (H. H.W.), Hoefsloot, E.H. (Lies), Schroeff, M.P. (Marc) van der, Kant, S.G. (Sarina), Rotteveel, L.J.C. (L. J.C.), Frints, S.G.M. (Suzanna), Hof, J.R. (J. R.), Stokroos, R.J. (Robert Jan), Vanhoutte, E.K. (Els), Admiraal, R.J. (Ronald), Feenstra, I. (I.), Kremer, H. (H.), Kunst, H.P.M. (Henricus P.M.), Pennings, R.J.E. (Ronald J.E.), Yntema, H.G. (H. G.), Essen, J.A. (Anthonie) van, Free, R.H. (Rolien), Klein-Wassink, J.S. (J. S.), Yntema, H.G., Pennings, R.J.E. (Ronald J. E.), Kremer, H. (Hannie), Wesdorp, M. (Mieke), de Koning Gans, P.A.M. (P. A M), Schraders, M. (Margit), Oostrik, J. (Jaap), Huynen, M. (Martijn), Venselaar, H. (Hanka), Beynon, A.J. (Andy J.), van Gaalen, J. (Judith), Piai, V. (Vitória), Voermans, N.C. (Nicol), Rossum, M.M. (Michelle) van, Hartel, B.P. (Bas P.), Lelieveld, S.H. (Stefan H.), Wiel, L. (Laurens), Verbist, B. (Berit), Rotteveel, L.J. (Liselotte J.), Dooren, M.F. (Marieke) van, Lichtner, P. (Peter), Kunst, H.P.M. (Henricus P. M.), Feenstra, I. (Ilse), Admiraal, R.J.C. (Ronald J. C.), van Dooren, M.F. (M. F.), de Gier, H.H.W. (H. H.W.), Hoefsloot, E.H. (Lies), Schroeff, M.P. (Marc) van der, Kant, S.G. (Sarina), Rotteveel, L.J.C. (L. J.C.), Frints, S.G.M. (Suzanna), Hof, J.R. (J. R.), Stokroos, R.J. (Robert Jan), Vanhoutte, E.K. (Els), Admiraal, R.J. (Ronald), Feenstra, I. (I.), Kremer, H. (H.), Kunst, H.P.M. (Henricus P.M.), Pennings, R.J.E. (Ronald J.E.), Yntema, H.G. (H. G.), Essen, J.A. (Anthonie) van, Free, R.H. (Rolien), Klein-Wassink, J.S. (J. S.), Yntema, H.G., Pennings, R.J.E. (Ronald J. E.), and Kremer, H. (Hannie)
- Abstract
Unraveling the causes and pathomechanisms of progressive disorders is essential for the development of therapeutic strategies. Here, we identified heterozygous pathogenic missense variants of LMX1A in two families of Dutch origin with progressive nonsyndromic hearing impairment (HI), using whole exome sequencing. One variant, c.721G > C (p.Val241Leu), occurred de novo and is predicted to affect the homeodomain of LMX1A, which is essential for DNA binding. The second variant, c.290G > C (p.Cys97Ser), predicted to affect a zinc-binding residue of the second LIM domain that is involved in protein–protein interactions. Bi-allelic deleterious variants of Lmx1a are associated with a complex phenotype in mice, including deafness and vestibular defects, due to arrest of inner ear development. Although Lmx1a mouse mutants demonstrate neurological, skeletal, pigmentation and reproductive system abnormalities, no syndromic features were present in the participating subjects of either family. LMX1A has previously been suggested as a candidate gene for intellectual disability, but our data do not support this, as affected subjects displayed normal cognition. Large variability was observed in the age of onset (a)symmetry, severity and progression rate of HI. About half of the affected individuals displayed vestibular dysfunction and experienced symptoms thereof. The late-onset progressive phenotype and the absence of cochleovestibular malformations on computed tomography scans indicate that heterozygous defects of LMX1A do not result in severe developmental abnormalities in humans. We propose that a single LMX1A wild-type copy is sufficient for normal development but insufficient for maintenance of cochleovestibular function. Alternatively, minor cochleovestibular developmental abnormalities could eventually lead to the progressive phenotype seen in the families.
- Published
- 2018
- Full Text
- View/download PDF
7. The diagnostic yield of whole-exome sequencing targeting a gene panel for hearing impairment in the Netherlands
- Author
-
Seco, C.Z. (Celia Zazo), Wesdorp, M. (Mieke), Feenstra, I. (Ilse), Pfundt, R. (Rolph), Hehir-Kwa, J. (Jayne), Lelieveld, S.H. (Stefan H.), Castelein, S. (Steven), Gilissen, C. (Christian), Wijs, I.J. (Ilse) de, Admiraal, R.J. (Ronald), Pennings, R.J.E. (Ronald J.E.), Kunst, H.P.M. (Henricus P.M.), van de Kamp, J.M. (Jiddeke M.), Tamminga, S. (Saskia), Houweling, A.C. (Arjan), Plomp, A. (Astrid), Maas, S.M. (Saskia), de Koning Gans, P.A.M. (P. A M), Kant, S.G. (Sarina), De Geus, C.M. (Christa M.), Frints, S.G.M. (Suzanna), Vanhoutte, E.K. (Els), Dooren, M.F. (Marieke) van, Boogaard, M.H. (Marie-José Henriëtte) van den, Scheffer, H. (Hans), Nelen, M.R. (Marcel), Kremer, H. (Hannie), Hoefsloot, E.H. (Lies), Schraders, M. (Margit), Yntema, H.G., Seco, C.Z. (Celia Zazo), Wesdorp, M. (Mieke), Feenstra, I. (Ilse), Pfundt, R. (Rolph), Hehir-Kwa, J. (Jayne), Lelieveld, S.H. (Stefan H.), Castelein, S. (Steven), Gilissen, C. (Christian), Wijs, I.J. (Ilse) de, Admiraal, R.J. (Ronald), Pennings, R.J.E. (Ronald J.E.), Kunst, H.P.M. (Henricus P.M.), van de Kamp, J.M. (Jiddeke M.), Tamminga, S. (Saskia), Houweling, A.C. (Arjan), Plomp, A. (Astrid), Maas, S.M. (Saskia), de Koning Gans, P.A.M. (P. A M), Kant, S.G. (Sarina), De Geus, C.M. (Christa M.), Frints, S.G.M. (Suzanna), Vanhoutte, E.K. (Els), Dooren, M.F. (Marieke) van, Boogaard, M.H. (Marie-José Henriëtte) van den, Scheffer, H. (Hans), Nelen, M.R. (Marcel), Kremer, H. (Hannie), Hoefsloot, E.H. (Lies), Schraders, M. (Margit), and Yntema, H.G.
- Abstract
Hearing impairment (HI) is genetically heterogeneous which hampers genetic counseling and molecular diagnosis. Testing of several single HI-related genes is laborious and expensive. In this study, we evaluate the diagnostic utility of whole-exome sequencing (WES) targeting a panel of HI-related genes. Two hundred index patients, mostly of Dutch origin, with presumed hereditary HI underwent WES followed by targeted analysis of an HI gene panel of 120 genes. We found causative variants underlying the HI in 67 of 200 patients (33.5%). Eight of these patients have a large homozygous deletion involving STRC, OTOA or USH2A, which could only be identified by copy number variation detection. Variants of uncertain significance were found in 10 patients (5.0%). In the remaining 123 cases, no potentially causative variants were detected (61.5%). In our patient cohort, causative variants in GJB2, USH2A, MYO15A and STRC, and in MYO6 were the leading causes for autosomal recessive and dominant HI, respectively. Segregation analysis and functional analyses of variants of uncertain significance will probably further increase the diagnostic yield of WES.
- Published
- 2017
- Full Text
- View/download PDF
8. Diagnostic exome sequencing in 266 Dutch patients with visual impairment
- Author
-
Haer-Wigman, L. (Lonneke), Zelst-Stams, W.A. van, Pfundt, R. (Rolph), Born, L.I. (Ingeborgh) van den, Klaver, C.C.W. (Caroline), Verheij, J.B. (Joke), Hoyng, C.B. (Carel), Breuning, M.H. (Martijn), Boon, C.J.F. (Camiel), Kievit, A.J.A. (Anneke J.A.), Verhoeven, V.J.M. (Virginie), Pott, J.W.R., Sallevelt, S.C.E.H. (Suzanne), Hagen, J.M. (Johanna) van, Plomp, A. (Astrid), Kroes, H.Y. (Hester), Lelieveld, S.H. (Stefan H.), Hehir-Kwa, J. (Jayne), Castelein, S. (Steven), Nelen, M.R. (Marcel), Scheffer, H. (Hans), Lugtenberg, D. (Dorien), Cremers, F.P.M. (Frans), Hoefsloot, E.H. (Lies), Yntema, H.G., Haer-Wigman, L. (Lonneke), Zelst-Stams, W.A. van, Pfundt, R. (Rolph), Born, L.I. (Ingeborgh) van den, Klaver, C.C.W. (Caroline), Verheij, J.B. (Joke), Hoyng, C.B. (Carel), Breuning, M.H. (Martijn), Boon, C.J.F. (Camiel), Kievit, A.J.A. (Anneke J.A.), Verhoeven, V.J.M. (Virginie), Pott, J.W.R., Sallevelt, S.C.E.H. (Suzanne), Hagen, J.M. (Johanna) van, Plomp, A. (Astrid), Kroes, H.Y. (Hester), Lelieveld, S.H. (Stefan H.), Hehir-Kwa, J. (Jayne), Castelein, S. (Steven), Nelen, M.R. (Marcel), Scheffer, H. (Hans), Lugtenberg, D. (Dorien), Cremers, F.P.M. (Frans), Hoefsloot, E.H. (Lies), and Yntema, H.G.
- Abstract
Inherited eye disorders have a large clinical and genetic heterogeneity, which makes genetic diagnosis cumbersome. An exome-sequencing approach was developed in which data analysis was divided into two steps: the vision gene panel and exome analysis. In the vision gene panel analysis, variants in genes known to cause inherited eye disorders were assessed for pathogenicity. If no causative variants were detected and when the patient consented, the entire exome data was analyzed. A total of 266 Dutch patients with different types of inherited eye disorders, including inherited retinal dystrophies, cataract, developmental eye disorders and optic atrophy, were investigated. In the vision gene panel analysis (likely), causative variants were detected in 49% and in the exome analysis in an additional 2% of the patients. The highest detection rate of (likely) causative variants was in patients with inherited retinal dystrophies, for instance a yield of 63% in patients with retinitis pigmentosa. In patients with developmental eye defects, cataract and optic atrophy, the detection rate was 50, 33 and 17%, respectively. An exome-sequencing approach enables a genetic diagnosis in patients with different types of inherited eye disorders using one test. The exome approach has the same detection rate as targeted panel sequencing tests, but offers a number of advantages. For instance, the vision gene panel can be frequently and easily updated with additional (novel) eye disorder genes. Determination of the genetic diagnosis improved the clinical diagnosis, regarding the assessment of the inheritance pattern as well as future disease perspective.
- Published
- 2017
- Full Text
- View/download PDF
9. Meier-Gorlin syndrome Clinical genetics and genomics
- Author
-
Munnik, S.A. (Sonja) de, Hoefsloot, E.H. (Lies), Roukema, J. (Jolt), Schoots, J. (Jeroen), Knoers, N.V.A.M. (Nine), Brunner, H.G., Jackson, A.P. (Andrew), Bongers, E. (Ernie), Munnik, S.A. (Sonja) de, Hoefsloot, E.H. (Lies), Roukema, J. (Jolt), Schoots, J. (Jeroen), Knoers, N.V.A.M. (Nine), Brunner, H.G., Jackson, A.P. (Andrew), and Bongers, E. (Ernie)
- Abstract
Meier-Gorlin syndrome (MGS) is a rare autosomal recessive primordial dwarfism disorder, characterized by microtia, patellar applasia/hypoplasia, and a proportionate short stature. Associated clinical features encompass feeding problems, congenital pulmonary emphysema, mammary hypoplasia in females and urogenital anomalies, such as cryptorchidism and hypoplastic labia minora and majora. Typical facial characteristics during childhood comprise a small mouth with full lips and micro-retrognathia. During ageing, a narrow, convex nose becomes more prominent. The diagnosis MGS should be considered in patients with at least two of the three features of the clinical triad of microtia, patellar anomalies, and pre- and postnatal growth retardation. In patients with short stature and/or microtia, the patellae should be assessed with care by ultrasonography before age 6 or radiography thereafter. Mutations in one of five genes (ORC1, ORC4, ORC6, CDT1, and CDC6) of the pre-replication complex, involved in DNA-replication, are detected in approximately 67-78 % of patients with MGS. Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly. Management should be directed towards in-depth investigation, treatment and prevention of associated problems, such as growth retardation, feeding problems, hearing loss, luxating patellae, knee pain, gonarthrosis, and possible pulmonary complications due to congenital pulmonary emphysema with or without broncho- or laryngomalacia. Growth hormone treatment is ineffective in most patients with MGS, but may be effective in patients in whom growth continues to decrease after the first year of life (usually growth velocity normalizes after the first year) and with low levels of IGF1. At present, few data is available about reproduction of females with MGS, but the risk of premature labor might be increased. Here, we propose experience-based guidelines for the regular care and treatment of MGS patients.
- Published
- 2015
- Full Text
- View/download PDF
10. Allelic mutations of KITLG, encoding KIT ligand, cause asymmetric and unilateral hearing loss and Waardenburg syndrome type 2
- Author
-
Zazo Seco, C. (Celia), Serrão De Castro, L. (Luciana), Nierop, J.W.I. van, Morín, M. (Matías), Jhangiani, S.N. (Shalini N.), Verver, E.J.J. (Eva J. J.), Schraders, M. (Margit), Maiwald, N. (Nadine), Wesdorp, M. (Mieke), Venselaar, H. (Hanka), Spruijt, L. (Liesbeth), Oostrik, J. (Jaap), Schoots, J. (Jeroen), Reeuwijk, J. (Jeroen) van, Lelieveld, S.H. (Stefan H.), Huygen, P.L.M. (Patrick), Insenser, M. (María), Admiraal, R.J. (Ronald), Pennings, R.J.E. (Ronald J.E.), Hoefsloot, E.H. (Lies), Arias-Vásquez, A. (Alejandro), Ligt, J. (Joep) de, Yntema, H.G., Jansen, J.H. (Joop H.), Muzny, D. (Donna), Huls, G. (Gerwin), Rossum, M.M. (Michelle) van, Lupski, J.R. (James R.), Moreno-Pelayo, M.A. (Miguel Angel), Kunst, H.P.M. (Henricus P.M.), Kremer, H. (Hannie), Zazo Seco, C. (Celia), Serrão De Castro, L. (Luciana), Nierop, J.W.I. van, Morín, M. (Matías), Jhangiani, S.N. (Shalini N.), Verver, E.J.J. (Eva J. J.), Schraders, M. (Margit), Maiwald, N. (Nadine), Wesdorp, M. (Mieke), Venselaar, H. (Hanka), Spruijt, L. (Liesbeth), Oostrik, J. (Jaap), Schoots, J. (Jeroen), Reeuwijk, J. (Jeroen) van, Lelieveld, S.H. (Stefan H.), Huygen, P.L.M. (Patrick), Insenser, M. (María), Admiraal, R.J. (Ronald), Pennings, R.J.E. (Ronald J.E.), Hoefsloot, E.H. (Lies), Arias-Vásquez, A. (Alejandro), Ligt, J. (Joep) de, Yntema, H.G., Jansen, J.H. (Joop H.), Muzny, D. (Donna), Huls, G. (Gerwin), Rossum, M.M. (Michelle) van, Lupski, J.R. (James R.), Moreno-Pelayo, M.A. (Miguel Angel), Kunst, H.P.M. (Henricus P.M.), and Kremer, H. (Hannie)
- Abstract
Linkage analysis combined with whole-exome sequencing in a large family with congenital and stable non-syndromic unilateral and asymmetric hearing loss (NS-UHL/AHL) revealed a heterozygous truncating mutation, c.286-303delinsT (p.Ser96Ter), in KITLG. This mutation co-segregated with NS-UHL/AHL as a dominant trait with reduced penetrance. By screening a panel of probands with NS-UHL/AHL, we found an additional mutation, c.200-202del (p.His67-Cys68delinsArg). In vitro studies revealed that the p.His67-Cys68delinsArg transmembrane isoform of KITLG is not detectable at the cell membrane, supporting pathogenicity. KITLG encodes a ligand for the KIT receptor. Also, KITLG-KIT signaling and MITF are suggested to mutually interact in melanocyte development. Because mutations in MITF are causative of Waardenburg syndrome type 2 (WS2), we screened KITLG in suspected WS2-affected probands. A heterozygous missense mutation, c.310C>G (p.Leu104Val), that segregated with WS2 was identified in a small family. In vitro studies revealed that the p.Leu104Val transmembrane isoform of KITLG is located at the cell membrane, as is wild-type KITLG. However, in culture media of transfected cells, the p.Leu104Val soluble isoform of KITLG was reduced, and no soluble p.His67-Cys68delinsArg and p.Ser96Ter KITLG could be detected. These data suggest that mutations in KITLG associated with NS-UHL/AHL have a loss-of-function effect. We speculate that the mechanism of the mutation underlying WS2 and leading to membrane incorporation and reduced secretion of KITLG occurs via a dominant-negative or gain-of-function effect. Our study unveils different phenotypes associated with KITLG, previously associated with pigmentation abnormalities, and will thereby improve the genetic counseling given to individuals with KITLG variants.
- Published
- 2015
- Full Text
- View/download PDF
11. Clinical utility gene card for: CHARGE syndrome - Update 2015
- Author
-
Ravenswaaij-Arts, C.M.A. (Conny) van, Blake, K. (Kim), Hoefsloot, E.H. (Lies), Verloes, A. (Alain), Ravenswaaij-Arts, C.M.A. (Conny) van, Blake, K. (Kim), Hoefsloot, E.H. (Lies), and Verloes, A. (Alain)
- Published
- 2015
- Full Text
- View/download PDF
12. TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy
- Author
-
Hofstra, J.M. (Julia), Coenen, M.J. (Marieke), Schijvenaars, M.M.V.A.P. (Mascha), Berden, J.H.M. (Jo H.), Vlag, J. (Johan) van der, Hoefsloot, E.H. (Lies), Knoers, N.V.A.M. (Nine), Wetzels, J.F.M. (Jack), Nijenhuis, T. (Tom), Hofstra, J.M. (Julia), Coenen, M.J. (Marieke), Schijvenaars, M.M.V.A.P. (Mascha), Berden, J.H.M. (Jo H.), Vlag, J. (Johan) van der, Hoefsloot, E.H. (Lies), Knoers, N.V.A.M. (Nine), Wetzels, J.F.M. (Jack), and Nijenhuis, T. (Tom)
- Abstract
Background: Activating mutations in the Transient Receptor Potential channel C6 (TRPC6) cause autosomal dominant focal segmental glomerular sclerosis (FSGS). TRPC6 expression is upregulated in renal biopsies of patients with idiopathic membranous glomerulopathy (iMN) and animal models thereof. In iMN, disease progression is characterized by glomerulosclerosis. In addition, a context-dependent TRPC6 overexpression was recently suggested in complement-mediated podocyte injury in e.g. iMN. Hence, we hypothesized that genetic variants in TRPC6 might affect susceptibility to development or progression of iMN. Methods & Results: Genomic DNA was isolated from blood samples of 101 iMN patients and 292 controls. By direct sequencing of the entire TRPC6 gene, 13 single nucleotide polymorphisms (SNPs) were identified in the iMN cohort, two of which were causing an amino acid substitution (rs3802829; Pro15Ser and rs36111323, Ala404Val). No statistically significant differences in genotypes or allele frequencies between patients and controls were observed. Clinical outcome in patients was determined (remission n = 26, renal failure n = 46, persistent proteinuria n = 29, follow-up median 80 months {range 51-166}). The 13 identified SNPs showed no association with remission or renal failure. There were no differences in genotypes or allele frequencies between patients in remission and progressors. Conclusions: Our data suggest that TRPC6 polymorphisms do not affect susceptibility to iMN, or clinical outcome in iMN.
- Published
- 2014
- Full Text
- View/download PDF
13. The phenotype of Floating-Harbor syndrome: Clinical characterization of 52 individuals with mutations in exon 34 of SRCAP
- Author
-
Nikkel, S.M. (Sarah), Dauber, A. (Andrew), Munnik, S.A. (Sonja) de, Connolly, M. (Meghan), Hood, R.L. (Rebecca L), Caluseriu, O. (Oana), Hurst, J.A. (Jane), Kini, U. (Usha), Nowaczyk, M.J.M., Afenjar, A. (Alexandra), Albrecht, B., Allanson, J.E. (Judith), Balestri, P. (Paolo), Ben-Omran, T. (Tawfeg), Brancati, F. (Fred), Cordeiro, I. (Isabel), Da Cunha, B.S. (Bruna Santos), Delaney, P.F. (Peter), Destrée, A. (Anne), Fitzpatrick, D.R. (David), Forzano, F. (Francesca), Ghali, N. (Neeti), Gillies, G. (Greta), Harwood, J., Hendriks, Y., Héron, D. (Delphine), Hoischen, A. (Alex), Honey, E.M. (Engela Magdalena), Hoefsloot, E.H. (Lies), Ibrahim, J. (Jennifer), Jacob, C. (Claire), Kant, S.G. (Sarina), Kim, C.A. (Chong), Kirk, E.P. (Edwin P), Knoers, N.V.A.M. (Nine), Lacombe, D. (Denis), Lee, C.Y. (Chung-Yee), Lo, I.F.M. (Ivan F M), Lucas, L.S. (Luiza S), Mari, F. (Francesca), Mericq, V. (Veronica), Moilanen, J.S. (Jukka S), Møller, S.T. (Sanne Traasdahl), Moortgat, S. (Stephanie), Pilz, D.T. (Daniela), Pope, K. (Kate), Price, S. (Susan), Renieri, A. (Alessandra), Sá, J. (Joaquim), Schoots, J. (Jeroen), Silveira, E.L. (Elizabeth L), Simon, M.E.H. (Marleen), Slavotinek, A. (Anne), Temple, I.K., Burgt, I. (Ineke) van der, Vries, B.B.A. (Bert) de, Weisfeld-Adams, J.D. (James D), Whiteford, M.L. (Margo L), Wierczorek, D. (Dagmar), Wit, J.M. (Jan), Yee, C.F.O. (Connie Fung On), Beaulieu, P. (Patrick), White, S.M. (Sue M), Bulman, B., Bongers, E. (Ernie), Brunner, H. (Han), Feingold, M. (Murray), Boycott, K.M. (Kym), Nikkel, S.M. (Sarah), Dauber, A. (Andrew), Munnik, S.A. (Sonja) de, Connolly, M. (Meghan), Hood, R.L. (Rebecca L), Caluseriu, O. (Oana), Hurst, J.A. (Jane), Kini, U. (Usha), Nowaczyk, M.J.M., Afenjar, A. (Alexandra), Albrecht, B., Allanson, J.E. (Judith), Balestri, P. (Paolo), Ben-Omran, T. (Tawfeg), Brancati, F. (Fred), Cordeiro, I. (Isabel), Da Cunha, B.S. (Bruna Santos), Delaney, P.F. (Peter), Destrée, A. (Anne), Fitzpatrick, D.R. (David), Forzano, F. (Francesca), Ghali, N. (Neeti), Gillies, G. (Greta), Harwood, J., Hendriks, Y., Héron, D. (Delphine), Hoischen, A. (Alex), Honey, E.M. (Engela Magdalena), Hoefsloot, E.H. (Lies), Ibrahim, J. (Jennifer), Jacob, C. (Claire), Kant, S.G. (Sarina), Kim, C.A. (Chong), Kirk, E.P. (Edwin P), Knoers, N.V.A.M. (Nine), Lacombe, D. (Denis), Lee, C.Y. (Chung-Yee), Lo, I.F.M. (Ivan F M), Lucas, L.S. (Luiza S), Mari, F. (Francesca), Mericq, V. (Veronica), Moilanen, J.S. (Jukka S), Møller, S.T. (Sanne Traasdahl), Moortgat, S. (Stephanie), Pilz, D.T. (Daniela), Pope, K. (Kate), Price, S. (Susan), Renieri, A. (Alessandra), Sá, J. (Joaquim), Schoots, J. (Jeroen), Silveira, E.L. (Elizabeth L), Simon, M.E.H. (Marleen), Slavotinek, A. (Anne), Temple, I.K., Burgt, I. (Ineke) van der, Vries, B.B.A. (Bert) de, Weisfeld-Adams, J.D. (James D), Whiteford, M.L. (Margo L), Wierczorek, D. (Dagmar), Wit, J.M. (Jan), Yee, C.F.O. (Connie Fung On), Beaulieu, P. (Patrick), White, S.M. (Sue M), Bulman, B., Bongers, E. (Ernie), Brunner, H. (Han), Feingold, M. (Murray), and Boycott, K.M. (Kym)
- Abstract
Background: Floating-Harbor syndrome (FHS) is a rare condition characterized by short stature, delays in expressive language, and a distinctive facial appearance. Recently, heterozygous truncating mutations in SRCAP were determined to be disease-causing. With the availability of a DNA based confirmatory test, we set forth to define the clinical features of this syndrome. Methods and results. Clinical information on fifty-two individuals with SRCAP mutations was collected using standardized questionnaires. Twenty-four males and twenty-eight females were studied with ages ranging from 2
- Published
- 2013
- Full Text
- View/download PDF
14. Kallmann syndrome and paranoid schizophrenia: A rare combination
- Author
-
Verhoeven, W.M.A. (Wim), Egger, J.I.M. (Jos), Hovens, J.E.J.M. (Hans), Hoefsloot, E.H. (Lies), Verhoeven, W.M.A. (Wim), Egger, J.I.M. (Jos), Hovens, J.E.J.M. (Hans), and Hoefsloot, E.H. (Lies)
- Abstract
Kallmann syndrome (KS) is a genetically heterogeneous and rare disorder characterised by the combination of hypothalamic hypogonadism and anosmia/hyposmia, a variable degree of intellectual disability and several somatic anomalies. In about one-third of the patients, mutations have been identified in at least seven different genes. Virtually no data are available about possible neuropsychiatric symptoms in KS. Here, a young adult male is described with a previous clinical diagnosis of KS and recent paranoid schizophrenia of which positive, but not negative symptoms, fully remitted upon treatment with antipsychotics. Neither genome-wide array analysis nor mutation analyses disclosed imbalances or mutations in any of presently known KS disease genes. This is the first report on a patient with KS and paranoid schizophrenia in whom extensive genetic analyses were performed. It is concluded that further studies are warranted in order to elucidate a possible increased risk for psychiatric symptoms in patients with KS.Copyright 2013 BMJ Publishing Group. All rights reserved.
- Published
- 2013
- Full Text
- View/download PDF
15. The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome
- Author
-
Bergman, J.E.H. (Jorieke), Ronde, W.A. (Willem) de, Jongmans, M.C.J. (Marjolijn), Wolffenbuttel, B.H.R. (Bruce), Drop, S.L.S. (Stenvert), Hermus, A.R.M.M. (Ad), Bocca, G. (Gianni), Hoefsloot, E.H. (Lies), Ravenswaaij-Arts, C.M.A. (Conny) van, Bergman, J.E.H. (Jorieke), Ronde, W.A. (Willem) de, Jongmans, M.C.J. (Marjolijn), Wolffenbuttel, B.H.R. (Bruce), Drop, S.L.S. (Stenvert), Hermus, A.R.M.M. (Ad), Bocca, G. (Gianni), Hoefsloot, E.H. (Lies), and Ravenswaaij-Arts, C.M.A. (Conny) van
- Abstract
Context: Kallmann syndrome (KS) and CHARGE syndrome are rare heritable disorders in which anosmia and hypogonadotropic hypogonadism co-occur. KS is genetically heterogeneous, and there are at least eight genes involved in its pathogenesis, whereas CHARGE syndrome is caused by autosomal dominant mutations in only one gene, the CHD7 gene. Two independent studies showed that CHD7 mutations can also be found in a minority of KS patients. Objective: We aimed to investigate whether CHD7 mutations can give rise to isolated KS or whether additional features of CHARGE syndrome always occur. Design: We performed CHD7 analysis in a cohort of 36 clinically well-characterized Dutch patients with KS but without mutations in KAL1 and with known status for the KS genes with incomplete penetrance, FGFR1, PROK2, PROKR2, and FGF8. Results: We identified three heterozygous CHD7 mutations. The CHD7-positive patients were carefully reexamined and were all found to have additional features of CHARGE syndrome. Conclusion: The yield of CHD7 analysis in patients with isolated KS seems very low but increases when additional CHARGE features are present. Therefore, we recommend performing CHD7 analysis in KS patients who have at least two additional CHARGE features or semicircular canal anomalies. Identifying a CHD7 mutation has important clinical implications for the surveillance and genetic counseling of patients. Copyright
- Published
- 2012
- Full Text
- View/download PDF
16. Clinical evaluation of 3 families with basal laminar drusen caused by novel mutations in the complement factor H gene
- Author
-
Ven, J.P.H. (Johannes P.) van de, Boon, C.J.F. (Camiel), Fauser, B.C.J.M. (Bart), Hoefsloot, E.H. (Lies), Smailhodzic, D. (Dzenita), Schoenmaker-Koller, F.E. (Frederieke), Klevering, B.J. (Jeroen), Klaver, C.C.W. (Caroline), Hollander, A.I. (Anneke), Hoyng, C.B. (Carel), Ven, J.P.H. (Johannes P.) van de, Boon, C.J.F. (Camiel), Fauser, B.C.J.M. (Bart), Hoefsloot, E.H. (Lies), Smailhodzic, D. (Dzenita), Schoenmaker-Koller, F.E. (Frederieke), Klevering, B.J. (Jeroen), Klaver, C.C.W. (Caroline), Hollander, A.I. (Anneke), and Hoyng, C.B. (Carel)
- Abstract
Objectives: To identify novel complement factor H (CFH) gene mutations and to specify the clinical characteristics in patients with basal laminar drusen (BLD), a clinical subtype of age-related macular degeneration. Methods: Twenty-one probands with BLD were included in this study. The ophthalmic examination included nonstereoscopic 30° color fundus photography, fluorescein angiography, and high-resolution spectral-domain optical coherence tomography. Renal function was tested by measurement of serum creatinine and urea nitrogen levels. Venous blood samples were drawn for genomic DNA, and all coding exons and splice junctions of the CFH gene were analyzed by direct sequencing. Results: In 3 families, we identified novel heterozygous mutations in the CFH gene: p.Ile184fsX, p.Lys204fsX, and c.1697-17--8del. Ten of 13 mutation carriers displayed the BLD phenotype with a wide variety in clinical presentation, ranging from limited macular drusen to extensive drusen in the posterior pole as well as the peripheral retina. Two patients with BLD developed end-stage kidney disease as a result of membranoproliferative glomerulonephritis type II. Conclusions: The early-onset BLD phenotype can be caused by heterozygous mutations in the CFH gene. Because some patients with BLD are at risk to develop membranoproliferative glomerulonephritis type II, we recommend that patients with extensive BLD undergo screening for renal dysfunction. Clinical Relevance: Elucidation of the clinical BLD phenotype will facilitate identification of individuals predisposed to developing disease-related comorbidity, such as membranoproliferative glomerulonephritis type II. Moreover, with upcoming treatment modalities targeting specific components of the complement system, early identification of patients with BLD and detection of the genetic defect become increasingly important.
- Published
- 2012
- Full Text
- View/download PDF
17. L1 retrotransposition can occur early in human embryonic development
- Author
-
Hurk, J.A.J.M. (José) van den, Meij, I.C. (Iwan), Carmen Seleme, M. (Maria) del, Kano, H. (Hiroki), Nikopoulos, K. (Konstantinos), Hoefsloot, E.H. (Lies), Sistermans, E.A. (Erik), Wijs, I.J. (Ilse) de, Mukhopadhyay, A. (Arijit), Plomp, A. (Astrid), Jong, P.T.V.M. (Paulus) de, Kazazian, H.H. (Haig), Cremers, F.P.M. (Frans), Hurk, J.A.J.M. (José) van den, Meij, I.C. (Iwan), Carmen Seleme, M. (Maria) del, Kano, H. (Hiroki), Nikopoulos, K. (Konstantinos), Hoefsloot, E.H. (Lies), Sistermans, E.A. (Erik), Wijs, I.J. (Ilse) de, Mukhopadhyay, A. (Arijit), Plomp, A. (Astrid), Jong, P.T.V.M. (Paulus) de, Kazazian, H.H. (Haig), and Cremers, F.P.M. (Frans)
- Abstract
L1 elements are autonomous retrotransposons that can cause hereditary diseases. We have previously identified a full-length L1 insertion in the CHM (choroideremia) gene of a patient with choroideremia, an X-linked progressive eye disease. Because this L1 element, designated L1CHM, contains two 3′-transductions, we were able to delineate a retrotransposition path in which a precursor L1 on chromosome 10p15 or 18p11 retrotransposed to chromosome 6p21 and subsequently to the CHM gene on chromosome Xq21. A cell culture retrotransposition assay showed that L1CHM is one of the most active L1 elements in the human genome. Most importantly, analysis of genomic DNA from the CHM patient's relatives indicated somatic and germ-line mosaicism for the L1 insertion in his mother. These findings provide evidence that L1 retrotransposition can occur very early in human embryonic development.
- Published
- 2007
- Full Text
- View/download PDF
18. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia
- Author
-
Dong, F. (Fan), Hoefsloot, E.H. (Lies), Schelen, A.M. (Anita), Broeders, C.A., Meijer, Y., Veerman, A.J., Touw, I.P. (Ivo), Löwenberg, B. (Bob), Dong, F. (Fan), Hoefsloot, E.H. (Lies), Schelen, A.M. (Anita), Broeders, C.A., Meijer, Y., Veerman, A.J., Touw, I.P. (Ivo), and Löwenberg, B. (Bob)
- Abstract
Severe congenital neutropenia (Kostmann syndrome) is characterized by profound absolute neutropenia and a maturation arrest of marrow progenitor cells at the promyelocyte-myelocyte stage. Marrow cells from such patients frequently display a reduced responsiveness to granulocyte-colony-stimulating factor (G-CSF). G-CSF binds to and activates a specific receptor which transduces signals critical for the proliferation and maturation of granulocytic progenitor cells. Here we report the identification of a somatic point mutation in one allele of the G-CSF receptor gene in a patient with severe congenital neutropenia. The mutation results in a cytoplasmic truncation of the receptor. When expressed in murine myeloid cells, the mutant receptor transduced a strong growth signal but, in contrast to the wild-type G-CSF receptor, was defective in maturation induction. The mutant receptor chain may act in a dominant negative manner to block granulocytic maturation.
- Published
- 1994
19. Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation
- Author
-
Dong, F. (Fan), Buitenen, C. van, Pouwels, K., Hoefsloot, E.H. (Lies), Löwenberg, B. (Bob), Touw, I.P. (Ivo), Dong, F. (Fan), Buitenen, C. van, Pouwels, K., Hoefsloot, E.H. (Lies), Löwenberg, B. (Bob), and Touw, I.P. (Ivo)
- Abstract
The granulocyte colony-stimulating factor receptor (G-CSF-R) transduces signals important for the proliferation and maturation of myeloid progenitor cells. To identify functionally important regions in the cytoplasmic domain of the G-CSF-R, we compared the actions of the wild-type receptor, two mutants, and a natural splice variant in transfectants of the mouse pro-B cell line BAF3 and two myeloid cell lines, 32D and L-GM. A region of 55 amino acids adjacent to the transmembrane domain was found to be sufficient for generating a growth signal. The immediate downstream sequence of 30 amino acids substantially enhanced the growth signaling in the three cell lines. In contrast, the carboxy-terminal part of 98 amino acids strongly inhibited growth signaling in the two myeloid cell lines but not in BAF3 cells. Truncation of this region lead to an inability of the G-CSF-R to transduce maturation signals in L-GM cells. An alternative carboxy tail present in a splice variant of the G-CSF-R also inhibited growth signaling, notably in both the myeloid cells and BAF3 cells, but appeared not to be involved in maturation.
- Published
- 1993
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.